Sunday, November 1, 2026

North Korea Enhances Missile Capabilities with New Multi-Target Strike Test

North Korea announced that it had successfully...

MISSILE BARRAGE: North Korea Launches Its Second Ballistic Missile at The South In Two Weeks—The Attacks Won’t Stop!

North Korea launched a ballistic missile into the East Sea, prompting heightened military alert from South Korea and the U.S.

Jaguar Land Rover Unveils the Ultimate Family Ride: The 2024 New Discovery SUV

Jaguar Land Rover (JLR) Korea announced on July 18 that it is launching the New Discovery 2024 Model, the seven-seater family SUV.

News1

Author's Latest

MediPost Signs CDMO Agreement With Qstem for Dermal Papilla Cell Culture Medium

MediPost will establish a commercial-scale production system for Qstem’s hiPSC-based dermal papilla cell culture medium, expanding its CDMO business beyond cell therapies.

Celltrion Completes Integration of France’s Gifrer, Targets European Pharmacy Network

Celltrion has completed the post-acquisition integration of French health care company Gifrer and plans to use its pharmacy network as a hub for expanding direct sales across Europe.

JW Pharmaceutical Files for South Korea Phase 3 Trial of Once-Every-Two-Weeks Obesity Drug

JW Pharmaceutical is seeking to advance Bofanglutide into a South Korean Phase 3 trial, aiming to halve the dosing frequency of GLP-1 obesity treatments from once weekly to once every two weeks.

HLB Panagene Posts Operating Profit in First Half, Accelerates PNA Business Expansion

HLB Panagene remained profitable in the first half as it expands its PNA business and accelerates development of antibody-oligonucleotide conjugates.

Celltrion Publishes Population Pharmacokinetic Analysis of Vegzelma in International Journal

Celltrion has published integrated population pharmacokinetic analysis results for its Avastin biosimilar Vegzelma, confirming pharmacokinetic similarity with the reference drug.

“Preparing for the Next Pandemic After COVID-19”…South Korea Accelerates Development of Homegrown mRNA Vaccines

The South Korean government is accelerating domestic mRNA vaccine development to secure an independent vaccine technology platform capable of responding rapidly to future pandemics.

Samsung Heavy Industries and KAIST Launch Next-Gen Ship Research Center: What AI and Robotics Mean for the Future of Maritime Tech

Samsung Heavy Industries inaugurates the SHI-KAIST Next Generation Ship Research Center at KAIST, Daejeon.

BMI2012: South Korea’s Next-Gen mRNA COVID-19 Vaccine Set for Clinical Trials

A consortium has received approval for the clinical trial of an mRNA-based COVID-19 variant vaccine, BMI2012.

Bonjo Capsule: A Game-Changer for Severe Myelofibrosis Patients – Here’s Why

The South Korean MFDS has approved a rare drug, Vonjo Capsule (Pacritinib Citrate), for treating myelofibrosis.

U.S. Military Resumes COVID-19 Inspections: What This Means for South Korea in 2026

The Korea Disease Control Agency and the U.S. military will resume quarantine operations for military and contracted aircraft post-COVID-19.

Revolutionary mRNA Discovery: How a Viral Strategy Tripled Stability and Boosted Protein Production

mRNA serves as a blueprint for protein production in cells but has a weakness: it degrades quickly once inside the cell.

Discover How GC WellBeing’s Laennec Transforms Pain Relief: A Game-Changer in Steroid Treatment!

GC WellBeing's study confirms pain relief effects of Laennec and its synergy with steroids, published in Scientific Reports.

Upstage Unveils Solar Pro 4: The Next-Gen AI Model Outperforming Global Giants

Upstage has unveiled its next-gen AI model Solar Pro 4, enhancing reasoning and agent capabilities over its predecessor.

LG and NVIDIA Join Forces: What to Expect from the Next-Gen AI-Powered Humanoid Robots in 2026?

LG accelerates the establishment of AI standards in humanoid robots, AI factories, and mobility using the NVIDIA platform.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.